Top Injectable Manufacturer in Ukraine – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 18
- 10 min read
Last Updated: July 18, 2026
TL;DR: Ukraine — one of Europe's largest countries by area, home to tens of millions of people and served by a Ministry of Health system that runs from national specialist institutes and oblast (regional) hospitals in Kyiv, Lviv, Dnipro, Kharkiv and Odesa down to city, rayon and community hospitals and a reformed primary-care network — depends on a reliable, compliant supply of sterile injectables, with demand weighted heavily toward emergency, trauma, anaesthesia and critical-care medicines. Every injectable placed on the market must be entered in the State Register of Medicines: the dossier is evaluated by the State Expert Center of the Ministry of Health of Ukraine (SEC) — whose registration, evaluation and market-control functions are being consolidated into the new independent Ukrainian Medical Agency — and the marketing authorisation is granted by order of the Ministry of Health; the file is prepared in Common Technical Document (CTD) format; the manufacturing site must hold GMP confirmation, with a Ukrainian GMP certificate issued by the State Service of Ukraine on Medicines and Drugs Control (Derzhliksluzhba) for makers outside the EU/UK mutual-recognition list; and labelling must be in Ukrainian. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer and CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/eCTD dossiers, drug master files and ICH stability data ready to support Ukrainian registration, Derzhliksluzhba GMP assessment, and hospital, Medical Procurement of Ukraine and international-agency procurement.
Key Takeaways
Market and regulatory pathway: every injectable must be entered in the State Register of Medicines, with the dossier evaluated by the State Expert Center of the Ministry of Health of Ukraine (SEC) — now being consolidated into the new independent Ukrainian Medical Agency — and the marketing authorisation granted by order of the Ministry of Health, filed in CTD format, with a Ukrainian GMP certificate from Derzhliksluzhba for makers outside the EU/UK mutual-recognition list and a Certificate of Pharmaceutical Product; Farbe Firma builds every dossier around SEC/Derzhliksluzhba requirements and the demand channelled through the Ministry of Health, oblast hospitals and Medical Procurement of Ukraine (MPU) via the ProZorro eCatalog.
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD dossier support: full CTD/eCTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data generated for Ukraine's temperate continental Climatic Zone II (25 °C / 60 % RH), Ukrainian-language artwork and leaflets, sterilisation and container-closure packages, drug master files and Certificate-of-Pharmaceutical-Product documentation for registration and Derzhliksluzhba GMP assessment.
End-to-end CDMO services: contract and third-party manufacturing across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — weighted toward the emergency, trauma, anaesthesia and critical-care injectables Ukraine needs most, with tamper-evident tender-ready packaging and resilient multimodal logistics through EU overland corridors and Black Sea ports.
Introduction: Why an Injectable Manufacturer in Ukraine Must Meet Global Standards
Ukraine is one of Europe's largest countries by area and home to tens of millions of people, served by a Ministry of Health system that runs from national specialist institutes and academies in Kyiv through oblast (regional) hospitals in Lviv, Dnipro, Kharkiv, Odesa and Vinnytsia down to city, rayon and community hospitals and a reformed primary-care network coordinated with the National Health Service of Ukraine. Across all of them the demand for sterile injectables is large and, in recent years, has shifted sharply toward emergency, trauma, anaesthesia and critical-care medicines — antibiotics, analgesics and anaesthetics, blood-volume expanders and electrolyte solutions, haemostatics, emergency cardiac and resuscitation drugs, and the anti-infectives and supportive injectables that intensive-care and surgical services consume in volume — alongside the everyday oncology, obstetric, paediatric and chronic-disease injectables any national health system needs. Every one of them has to reach hospitals sterile, correctly labelled and exactly to specification, batch after batch, whether it is destined for a national institute in Kyiv or a frontline regional hospital. As Ukraine sustains and rebuilds its health services, its health security depends on a dependable, resilient injectable supply.
Ukraine has a domestic pharmaceutical industry, but it still imports a wide range of finished medicines and much of its active-pharmaceutical-ingredient base, which makes a reliable overseas manufacturing partner strategically important — especially for the specialty, emergency and critical-care injectables where demand has outpaced local capacity. That partner must clear a demanding, EU-aligned regulatory pathway: every product must be entered in the State Register of Medicines, with the registration dossier evaluated by the State Expert Center of the Ministry of Health of Ukraine (SEC) — whose registration, evaluation and pharmacovigilance functions are being consolidated into the new independent Ukrainian Medical Agency — and the marketing authorisation granted by order of the Ministry of Health; the dossier must be prepared in the Common Technical Document (CTD) format; the manufacturing site must hold GMP confirmation, and a maker outside the EU/UK mutual-recognition list must obtain a Ukrainian GMP certificate from the State Service of Ukraine on Medicines and Drugs Control (Derzhliksluzhba), supported by a Certificate of Pharmaceutical Product; and labelling and product information must be in Ukrainian. Because Ukraine is harmonising its rules with the European Union and controls quality closely, the bar is real — and an injectable manufacturer that wants to serve Ukraine well has to treat these requirements not as afterthoughts but as core design inputs, which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Ukraine Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Ukraine runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so a Ukrainian importer, hospital or procurement agency can consolidate many product needs, and especially the emergency and critical-care injectables demand has concentrated on, with a single qualified source. Because Ukrainian registration and GMP confirmation involve document assessment and, for non-EU sites, a Derzhliksluzhba review that can be conducted remotely by videoconference, a manufacturer whose WHO-GMP certificate, plant and Certificate of Pharmaceutical Product are ready for that scrutiny makes registration far more predictable for its local partner.
The second differentiator is registration and market-access support built specifically around Ukraine. Because the SEC reviews dossiers in CTD format under increasingly EU-aligned rules, a strong partner prepares complete, review-ready CTD/eCTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a WHO-GMP certificate — the documentation a Ukrainian marketing-authorisation holder's regulatory team needs to enter a product in the State Register and to secure Derzhliksluzhba GMP confirmation. It supplies Ukrainian-language artwork and package inserts and packages products to compete in the channels through which the system actually buys medicines: Medical Procurement of Ukraine (MPU), the central state agency that runs the medical section of the ProZorro market (the eCatalog), together with hospital-level tenders and the international procurement organisations that continue to support the country. Because logistics into Ukraine demand realism, the right partner plans resilient multimodal routing — EU overland corridors through Poland and neighbouring member states and Black Sea shipping — and helps its partner assemble every certificate and sample a tender will ask for. This combination of manufacturing depth and Ukraine-specific dossier, labelling and logistics support is what separates a true injectable manufacturing partner for Ukraine from a mere exporter.
Quality Systems Behind Every Batch We Ship to Ukraine
Every Farbe Firma injectable batch destined for Ukraine is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release — the batch documentation the SEC's evaluators, Derzhliksluzhba's GMP assessors and a Ukrainian marketing-authorisation holder's regulatory-affairs team need for registration and quality-control verification — so reviewers can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under long-term conditions appropriate to Ukraine's temperate continental climate — the ICH Climatic Zone II condition of 25 °C / 60 % RH — alongside accelerated (40 °C / 75 % RH) testing and a photostability challenge where relevant, so registered shelf lives and handling instructions reflect how the product will actually be stored and transported, including cold-chain guidance where a product requires it and freeze-protection advice for winter overland movement across EU corridors and on to hospitals nationwide.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Ukraine for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, analgesic, haemostatic and blood-volume, gastrointestinal, anti-emetic, vitamin and specialty ranges — the categories Ukrainian hospitals, importers and procurement agencies need most, with a deliberate strength in the emergency, trauma, anaesthesia and critical-care injectables on which surgical and intensive-care services depend. For Ukrainian partners we supply finished sterile injectables ready for registration, with market-specific strengths, fill volumes, Ukrainian-language artwork and tamper-evident tender packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its CTD data package and Certificate of Pharmaceutical Product ready for the marketing-authorisation holder's State Register filing and Derzhliksluzhba GMP assessment.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full hospital, regional and central procurement supply. We prepare complete CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, a Certificate of Pharmaceutical Product and a WHO-GMP certificate, and Ukrainian-language inserts and artwork. Our regulatory, manufacturing and logistics teams coordinate registration timelines, the Derzhliksluzhba GMP assessment (including remote videoconference inspection where required), line slots and resilient shipping through EU overland corridors and Black Sea ports as a single, managed programme rather than a series of disconnected transactions — and, because we already export to 30+ countries, our partners inherit documentation and processes that are used to satisfying strict tender and regulatory review.
Buyers stay with Farbe Firma because of audit-readiness and communication. Ukrainian importers, distributors and the procurement teams that serve the Ministry of Health, the oblast hospitals and Medical Procurement of Ukraine are welcomed onto the plant floor and into the compounding and filling suites — in person or by remote and virtual audit; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing and supply, sterile-process design, stability strategy for a temperate Zone II climate, CTD dossier structure, State Register registration and Derzhliksluzhba GMP confirmation, and hospital, MPU and international-agency tender documentation in real detail. For an importer, hospital or procurement agency that has to answer to the regulator and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Ukraine?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support registration in Ukraine, with the WHO-GMP certificate and Certificate of Pharmaceutical Product required for the State Register and for the Ukrainian GMP certificate issued by the State Service of Ukraine on Medicines and Drugs Control (Derzhliksluzhba), and we make our plant and documentation available for its assessment — including remote videoconference review where an on-site inspection is not practicable.
How does Farbe Firma support medicine registration in Ukraine?
We provide complete CTD/eCTD modules with drug master files, ICH Q1A stability (for temperate Climatic Zone II) and ICH Q1B photostability data, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a WHO-GMP certificate. This is the technical documentation a Ukrainian marketing-authorisation holder's regulatory team needs to have the dossier evaluated by the State Expert Center of the Ministry of Health (SEC) — now being consolidated into the Ukrainian Medical Agency — to obtain the marketing authorisation by Ministry of Health order and to secure GMP confirmation from Derzhliksluzhba. We also supply Ukrainian-language artwork and package inserts and support the registration through its lifecycle as the rules align with the EU.
Can Farbe Firma supply injectables for Ukrainian hospital and Medical Procurement of Ukraine tenders?
Yes. Much of Ukraine's public demand runs through Medical Procurement of Ukraine (MPU) — the central state agency that operates the medical eCatalog on the ProZorro system — alongside hospital-level tenders, private importers and the international procurement organisations that continue to support the country. We package products to be tender-ready — with the right strengths, fill volumes, Ukrainian-language artwork and tamper-evident presentations — and provide the registration dossier, WHO-GMP evidence, Certificate of Pharmaceutical Product and samples that a marketing-authorisation holder or procurement team needs to qualify a source and compete.
How does Farbe Firma handle GMP confirmation and logistics for Ukraine?
Because Farbe Firma is a non-EU manufacturer, our Ukrainian partner obtains a Ukrainian GMP certificate from Derzhliksluzhba; we provide the site master file, WHO-GMP certificate and supporting documentation and make our plant available for assessment, which can be conducted remotely by videoconference where an on-site visit is not practicable. For delivery we plan resilient multimodal routing — EU overland corridors through Poland and neighbouring member states, plus Black Sea shipping — with stability data for temperate Climatic Zone II (25 °C / 60 % RH), cold-chain handling where a product requires it and freeze-protection guidance for winter transport, so consignments reach hospitals nationwide intact.
What is the minimum order quantity for injectable contract manufacturing for Ukraine?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-importer launch quantities as well as full hospital, regional and central procurement-scale supply for the Ukrainian market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments